Page last updated: 2024-12-06

diazobenzenesulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

diazobenzenesulfonic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID67540
SCHEMBL ID937040
MeSH IDM0040597

Synonyms (18)

Synonym
diazobenzenesulfonic acid
4-sulfobenzenediazonium
benzenediazonium, 4-sulfo-
dasa
diazobenzenesulfonate
4-sulfophenyldiazonium
diazobenzenesulphonate
2154-66-7
diazonium salt of sulfanilic acid
benzenediazonium, p-sulfo-
4-sulphodiazobenzene
diazobenzene sulfonate
p-diazoniumbenzenesulfonic acid
SCHEMBL937040
Q27294811
DTXSID00862847
4-sulfobenzene-1-diazonium
AKOS040745742

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The GABA antagonists 2-(3-carboxypropyl)-3-amino-4-methyl-6-phenylpyridazinium chloride (SR 95103) and 3-alpha-hydroxy-16-imino-5 beta-17-aza-androstan-11-one (R 5135) shifted and suppressed the dose-response curve of GABA on diazepam binding."( GABAA receptor populations bind agonists and antagonists differentially and with opposite affinities.
Maksay, G, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-199059 (59.60)18.7374
1990's19 (19.19)18.2507
2000's5 (5.05)29.6817
2010's3 (3.03)24.3611
2020's13 (13.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.92%)5.53%
Reviews2 (1.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other100 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]